02 June 2026 : Clinical Research
Ciprofol-Esketamine Versus Ciprofol-Remifentanil in Hysteroscopic Endometrial Polypectomy: A Randomized Controlled Trial
Zhong Zhang ABC 1, Zhixu Wang BC 1, Wanwan Gong DEF 1, Wei Jiang AF 1*, Longjiao Zheng DEF 1, Zhiyang Yu AEF 1DOI: 10.12659/MSM.952468
Med Sci Monit 2026; 32:e952468
Table 1 Patient demographics and baseline characteristics.
| Variable | CK (n=60) | CR (n=60) | χ2/t | P |
|---|---|---|---|---|
| Age (years) | 44.6±8.9 | 45.6±7.7 | 0.677 | 0.512 |
| Height (cm) | 160.0±4.6 | 159.9±5.3 | 0.292 | 0.771 |
| Weight (kg) | 58.1±7.3 | 59.8±5.6 | −1.435 | 0.154 |
| BMI (kg/m) | 22.7±2.6 | 23.4±1.8 | −1.794 | 0.076 |
| ASA physical status | 1.429 | 0.319 | ||
| I | 15 (25%) | 21 (35%) | ||
| II | 45 (75%) | 39 (65%) | ||
| Comorbidities | 2.315 | 0.502 | ||
| HBP | 8 (13.3%) | 10 (16.7%) | ||
| DM | 1 (1.7%) | 3 (5%) | ||
| Hypothyroidism | 1 (1.7%) | 0 (0%) | ||
| Continuous variables are presented as mean (standard deviation), and categorical variables as n (%). ASA – American Society of Anesthesiologists; BMI – body mass index; CK – ciprofol-esketamine regimen; CR – ciprofol-remifentanil regimen; DM – diabetes mellitus; HBP – high blood pressure. | ||||